ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1070

Seroreactivity Against Recombinant Citrullinated Myosin Is Associated with Measures of Diastolic Dysfunction in Patients with Rheumatoid Arthritis

Christian Geier1, Justyna Fert-Bober2, Jon T. Giles1, Cesare Russo1, Sabahat Bokhari3, Aylin Tugcu1, Jenny Van Eyk2 and Joan Bathon1, 1Columbia University, New York, NY, 2Cedars-Sinai Medical Center, Los Angeles, CA, 3Cardiology, Columbia University, New York, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: autoantibodies, Cardiovascular disease, citrullination, myocardial involvement and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Diastolic dysfunction and heart failure with preserved EF are more prevalent in RA. We have previously shown increased staining for citrullinated substrates in necropsied hearts of RA patients. We hypothesized that individuals with RA may generate antibodies against citrullinated myocardial proteins and that such antibodies may be associated with left ventricular (LV) dysfunction.


Methods:

59 sera from RA patients enrolled in a cohort study were incubated with uncitrullinated or citrullinated (exposed to peptidyl-arginine-deiminase-2 [PAD-2]) myocardial proteins (actin, myosin, tropomyosin, and troponin). Fluorescent anti-human IgG Fc antibody was added, rinsed, and mean fluorescence intensities (MFI) were recorded. Demographics, RA characteristics, and measures of LV function were compared between highest and lowest MFI tertiles for each protein in both citrullinated and uncitrullinated forms. The associations of anti-myocardial antibodies with measures of cardiac function, assessed by 3D echocardiography, were modeled using generalized linear models, adjusting for relevant confounders (variables associated with both LV function and seroreactivity to anti-myocardial proteins).


Results:

Patient sera with the highest tertile of seroreactivity against citrullinated (but not uncitrullinated) myosin showed multiple differences (p < 0.05) in measures of diastolic function: E/A ratio (0.95 vs 1.05), mean S wave (8.80 vs 10.09) and E/E’ ratio (9.64 vs 7.86) all indicated better diastolic function for patients in the lowest tertile. Systolic function between the seroreactivity tertiles was not different. Levels of other myocardial protein antibodies were not associated with diastolic function with the exception of S wave for citrullinated tropomyosin (p = 0.021). Multivariable analyses showed that the diastolic parameters E/E’ ratio and S wave (mean) remained significantly associated after controlling for RA duration and Tender Joint Count, previously identified potential confounders (Fig. 1).


Conclusion:

These data suggest that RA patients may generate antibodies against citrullinated myosin and that this may contribute to myocardial dysfunction in RA. Analyses of additional patient sera and ultimately verifying this observation in human myocardial tissue are needed.


Fig. 1: E/E’ ratio and S wave (mean) by tertiles of reactivity to citrullinated myosin.

E/E’ ratio and S wave (mean) are echocardiographic parameters that are increased (E/E’ ratio) and decreased (S wave [mean]) in diastolic dysfunction.



Disclosure: C. Geier, None; J. Fert-Bober, None; J. T. Giles, None; C. Russo, None; S. Bokhari, None; A. Tugcu, None; J. Van Eyk, None; J. Bathon, None.

To cite this abstract in AMA style:

Geier C, Fert-Bober J, Giles JT, Russo C, Bokhari S, Tugcu A, Van Eyk J, Bathon J. Seroreactivity Against Recombinant Citrullinated Myosin Is Associated with Measures of Diastolic Dysfunction in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/seroreactivity-against-recombinant-citrullinated-myosin-is-associated-with-measures-of-diastolic-dysfunction-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/seroreactivity-against-recombinant-citrullinated-myosin-is-associated-with-measures-of-diastolic-dysfunction-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology